YishengBio Co., Ltd. is a global, fully integrated biopharmaceutical company headquartered in Beijing. The Company is engaged in discovering, developing and commercializing innovative vaccines and biotherapeutics for cancers and infectious diseases using the novel PIKA® immunomodulating technology. Learn more at www.yishengbio.com.
Creating the industry’s first shared development platform backed by a shared data record, Zus aims to bring about a better health data reality by empowering a wave of new, digital-first healthcare builders who will create digital health technologies and services that are cheaper, more customizable, and more personalized. This vision drives Zus to proactively connect the largest array of traditional medical providers to novel health data sources so that health data becomes frictionless to use. Learn more at www.zushealth.com.